CPhI North America 2017
November 23, 2016
CPhI North America | May 16–18 | Philadelphia | Booth 2930
Want to Eliminate Clinical Trials for Your Topical Products?
Ask Us How!
A recent guidance from the FDA will allow acyclovir cream products to bypass human clinical trials, replacing them with a method using in vitro release testing (IVRT) and in vitro permeation testing (IVPT). Let Diteba, a division of Nutrasource, show you how you may be able to save substantial time and money in your development program.
Theo Kapanadze, D.Sc., Ph.D., co-founder and chief scientific officer of Diteba, will also be presenting on “The Advances in Bioequivalence Assessment of Generic Topical Drugs,” at 11:30 a.m. Wednesday, May 17.
Schedule a meeting with us
Back to News